/* TEAM */

Founder & CEO: Artem Shakin
Discipline: Computational biology, gene therapy, AI-augmented R&D
Site: https://nightboxllc.com
Twitter: @ArtemShkin
Location: Greater Los Angeles, California, USA
Email: artem@nightboxllc.com

/* COMPANY */

Name: Nightbox LLC
Founded: 2026-02
State of Incorporation: Wyoming, USA
Operations: Greater Los Angeles, California
Industry: Biotechnology / Gene Therapy / Solid Tumor Oncology
NAICS: 541714
EIN: 39-4373044
Lead Asset: NKG2D-LIF6 chimeric receptor-effector AAV9 platform
Slogan: Cancer is a reversion. We block it.

/* AGENT INFRASTRUCTURE */

Research agent: Anthropic Claude (via Vercel AI Gateway)
Runtime: Vercel Edge (V8 isolate sandbox)
Stack: TypeScript, Node, Anthropic SDK, custom prompt-router
Public chat agent: Nightbox Live Copilot (bilingual EN/RU)

/* THANKS */

To every researcher whose published work made the chimera possible:
- Vazquez et al. (2018) for characterizing elephant LIF6
- Sulak et al. (2016) for elephant TP53 copy-number biology
- Abegglen et al. (2015) for the foundational elephant cancer-resistance work
- Bauer et al. (1999) for the original NKG2D-MICA characterization

/* SITE */

Last update: 2026/04
Standards: HTML5, CSS3, JSON-LD (schema.org), Atom 1.0, JSON Feed 1.1
Discoverability: /llms.txt, /llms-full.txt, /.well-known/ai.txt
Feeds: /feed.xml, /feed.json
Components: Vanilla, Vercel Edge, Anthropic Claude
Software: Built with one founder + one AI agent

# Wyoming-incorporated. LA-area operating. Bootstrapped.